GLAXF GSK plc
Price Chart
Executive Summary
GSK executives and directors increased their shareholdings through dividend reinvestments in April 2026. CEO Luke Miels, CFO Julie Brown, and other senior leaders acquired ordinary shares and ADSs at prices around £21.67 and $58–$59. The transactions were automatic reinvestments under deferred bonus and pension plans, not discretionary purchases.
Actionable Insight
These are routine, non-discretionary transactions tied to dividend reinvestment plans and do not signal new confidence or strategic outlook. Traders should not interpret them as bullish indicators. Monitor for any additional discretionary purchases or sales outside of automatic plans.
Key Facts
- CEO Luke Miels acquired 1,178 ordinary shares at £21.67 each on April 14, 2026, via dividend reinvestment in the Deferred Annual Bonus Plan.
- CFO Julie Brown acquired 1,553 ordinary shares at £21.67 each on April 14, 2026, under the same plan.
- Multiple executives and non-executive directors acquired ADSs on April 9 and April 14, 2026, at prices between $58.35 and $59.17.
- Transactions occurred on the London Stock Exchange (XLON) and New York Stock Exchange (XNYS).
- Diana Conrad also acquired 11.357 ADSs at $58.3499 on April 13, 2026, under a pension plan.
Financial Impact
Total insider share acquisitions valued at approximately $125,000–$150,000 across all reported transactions.
Risk Factors
- Misinterpretation of automatic reinvestments as positive insider sentiment.
- Limited market impact due to small transaction sizes relative to company market cap.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001654954-26-003598 |
| Document: 0001654954-26-003598-index-headers.html | 0001654954-26-003598 |
| Document: 0001654954-26-003598-index.html | 0001654954-26-003598 |
| Document: 0001654954-26-003598.txt | 0001654954-26-003598 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
today
|
6-K
| — | awaiting T+5 | — | — |
|
Jun 9, 2026
today
|
6-K
| — | awaiting T+5 | — | — |
|
Jun 1, 2026
8d ago
|
6-K
| $24.25 $24.66 | ▲ +1.69% | ▲ +4.44% | $24.66 (+1.69%) |
|
Jun 1, 2026
8d ago
|
6-K
| $24.25 $24.66 | ▲ +1.69% | ▲ +4.44% | $24.66 (+1.69%) |
|
May 28, 2026
12d ago
|
6-K
| $24.58 $24.66 | ▲ +0.33% | ▲ +0.01% | $24.66 (+0.33%) |
|
May 27, 2026
13d ago
|
6-K
| $25.57 $23.94 | ▼ −6.37% | ▼ −7.58% | $24.66 (−3.56%) |
|
May 26, 2026
14d ago
|
6-K
| $25.50 $24.25 | ▼ −4.90% | ▼ −5.99% | $24.66 (−3.29%) |
|
May 26, 2026
14d ago
|
6-K
| $25.50 $24.25 | ▼ −4.90% | ▼ −5.99% | $24.66 (−3.29%) |
|
May 22, 2026
18d ago
|
6-K
| $26.00 $24.25 | ▼ −6.73% | ▼ −8.39% | $24.66 (−5.15%) |
|
May 20, 2026
20d ago
|
6-K
| $25.70 $25.57 | ▼ −0.51% | ▼ −1.74% | $24.66 (−4.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access